Skip to content

The effect of oxygen therapy during chemotherapy on nausea and vomiting.

The effect of oxygen therapy during chemotherapy on severity of chemotherapy-induced nausea and vomiting.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201305226481N4
Enrollment
Unknown
Registered
2013-06-02
Start date
2013-07-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer. Malignant neoplasms

Interventions

Oxygen therapy 5 lit/min with simple face mask during chemotherapy..
Treatment - Drugs
Oxygen therapy 5 lit/min with simple face mask during chemotherapy.

Sponsors

Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1- First cycle of chemotherapy 2- Use of intravenous chemotherapeutic agents with moderate and severe effect of nausea and vomiting 3- Administration to hospital for chemotherapy 4- Ability to communication 5- Literate Exclusion Criteria: 1- Psychiatric disorders 2- Gastrointestinal and brain malignancy 3- Electrolyte imbalance 4- Metabolic disorders that caused nausea and vomiting 5- Drug abuse and Alcohol 6- Use of opioid drugs with self-control pump 7- Simultaneous radiotherapy 8- Disorders in inner ear

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Nausea and Vomiting. Timepoint: pre and post intervention in two groups. Method of measurement: The Index of Nausea, Vomiting and Retching (INVR).

Secondary

MeasureTime frame
Quality of life related to nausea and vomiting. Timepoint: Pre and post intervention in two groups. Method of measurement: The Osoba’ Nausea and Emesis Module.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Soleimani

Semnan University of Medical Sciences

soli257@yahoo.com+98 23 1335 4191

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026